Bliss GVS Pharma Fined ₹3.6 Lakhs by BSE, NSE

Bliss GVS Pharma Ltd has been fined ₹1,80,000 (excluding GST) by both BSE and NSE for non-compliance with Regulation 17(1) of SEBI Listing Regulations, specifically related to board composition and failure to appoint a woman director. The total fine amounts to ₹3,60,000 (excluding GST). The company has paid the fines, which represent approximately 0.000269% of its market capitalization. The delay in disclosure was attributed to internal coordination and verification, and the company is strengthening its internal mechanisms to ensure timely compliance.